Clinicians treating patients with COVID-19  who are at risk for progression to acute disease should be aware of potential drug–drug interactions when the oral antiviral treatment nirmatrelvir/ritonavir (Paxlovid—Pfizer) is administered to people taking common cardiovascular drugs, experts warn in a new Journal of the American College of Cardiology article.

A recent survey from the Institute for Safe Medication Practices (ISMP) puts the pharmacist’s role during code situations into focus.

Compared with more than 3 million unexposed pregnancies, antidepressant-exposed pregnancies could not be directly correlated to a higher risk of autism spectrum disorder, ADHD, learning or developmental speech/language disorders, developmental coordination disorder, intellectual disability, or behavioral disorders, according to new research published in JAMA Internal Medicine.

The Michigan Department of Licensing and Regulatory Affairs (LARA) has released a new interpretation of the Michigan Public Health Code to enable pharmacists to partner with physicians so that the pharmacists directly dispense hormonal birth control.

New CDC data show that 19 states and 2 territories have at least 35% of residents with adult obesity. That figure is more than two times the number of states with high adult obesity prevalence recorded in 2018.